As of 2026-10-17, the EV/EBITDA ratio of Fortress Biotech Inc (FBIO) is -0.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FBIO's latest enterprise value is -94.85 mil USD. FBIO's TTM EBITDA according to its financial statements is 167.39 mil USD. Dividing these 2 quantities gives us the above FBIO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 17.5x | 17.1x |
| Forward P/E multiples | 20.5x - 23.3x | 23.0x |
| Fair Price | 79.40 - 122.13 | 105.76 |
| Upside | 4146.1% - 6431.1% | 5555.4% |
| Date | EV/EBITDA |
| 2026-10-14 | -0.56 |
| 2026-10-13 | -0.55 |
| 2026-10-12 | -0.52 |
| 2026-10-09 | -0.51 |
| 2026-10-08 | -0.52 |
| 2026-10-07 | -0.53 |
| 2026-10-06 | -0.53 |
| 2026-10-05 | -0.52 |
| 2026-10-02 | -0.53 |
| 2026-10-01 | -0.53 |
| 2026-09-30 | -0.51 |
| 2026-09-29 | -0.50 |
| 2026-09-28 | -0.51 |
| 2026-09-25 | -0.49 |
| 2026-09-24 | -0.49 |
| 2026-09-23 | -0.47 |
| 2026-09-22 | -0.45 |
| 2026-09-21 | -0.46 |
| 2026-09-18 | -0.44 |
| 2026-09-17 | -0.44 |
| 2026-09-16 | -0.45 |
| 2026-09-15 | -0.44 |
| 2026-09-14 | -0.44 |
| 2026-09-11 | -0.44 |
| 2026-09-10 | -0.43 |
| 2026-09-09 | -0.42 |
| 2026-09-08 | -0.40 |
| 2026-09-04 | -0.40 |
| 2026-09-03 | -0.40 |
| 2026-09-02 | -0.40 |
| 2026-09-01 | -0.41 |
| 2026-08-31 | -0.39 |
| 2026-08-28 | -0.39 |
| 2026-08-27 | -0.38 |
| 2026-08-26 | -0.38 |
| 2026-08-25 | -0.38 |
| 2026-08-24 | -0.36 |
| 2026-08-21 | -0.37 |
| 2026-08-20 | -0.39 |
| 2026-08-19 | -0.37 |
| 2026-08-18 | -0.36 |
| 2026-08-17 | -0.38 |
| 2026-08-14 | -0.36 |
| 2026-08-13 | -0.35 |
| 2026-08-12 | -0.39 |
| 2026-08-11 | -0.42 |
| 2026-08-10 | -0.39 |
| 2026-08-07 | -0.41 |
| 2026-08-06 | -0.39 |
| 2026-08-05 | -0.38 |